Stefaan Van Gool, MD, PhD.
Medical Director of Translational Oncology at the IOZK
Tumor immunologist specializing in brain tumors
Stefan Van Gool, MD, PhD, is a specialist in pediatric hematology-oncology with a focus on brain tumors. From 2001 to 2004, he was head of clinical research at the Research Foundation Flanders. Between 2006 and 2016, he was a professor at the Faculty of Medicine of the Catholic University of Leuven. From 2012 to 2015, he was head of the Laboratory of Pediatric Immunology. He is the author of nearly 200 scientific articles in international scientific journals.
In recognition of his scientific achievements, he received the following awards:
1995 Schweißguth Prize from the International Society of Pediatric Oncology
1996 Nycomed Prize from the International Society of Pediatric Oncology
1998 Cancer Research Prize from the Rik en Nel Wouters Foundation (with Ludwig Van den Hove)
Between 2005 and 2009, he was coordinator of the European expert group for high-grade glioma.
He has been a member of the High Health Council in Belgium since 2008.
From 2014 to 2017, he was co-chair of the European Society for Pediatric Oncology's brain tumor working group.
At the IOZK, he is the medical director and responsible for planning and implementing IOZK immunotherapy. He is a qualified person (GMP) in drug manufacturing.
"Since every tumor is different, the best results are achieved by using the patient's own dendritic cells to attack the unique set of tumor cells."
Stefaan Van Gool, MD, PhD.
Collection: Scientific articles and international publications by Stefaan Van Gool, MD, PhD
Further information on this topic:
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de